Track record · closed signal

Novo Nordisk A/S (NVO) — closed signal from May 25, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on August 23, 2026.

Predicted vs. what happened

NVO price · publication thesis → realized outcomesplit-adjusted
$44.39 Published $46.90 Target $46.74 Window close $51.46 Peak
$42.41 – $43.87Entry zone — fair-value band
$44.39Published — price the day we called it
$46.90Target — the price the thesis aimed for
$51.46Peak — highest point inside the window, not a realized return
$46.74Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 31 days.

Peak price
$51.46
peak on July 29, 2026 — not a realized return
Peak gain
+15.9%
peak, from the publication price
Window close
$46.74
end-of-window price, context only
Days to target
31
Window
May 25, 2026 – August 23, 2026

The thesis — published May 25, 2026

Predicted growth
+7%
over the measurement window
Target price
$46.90
the price the thesis aimed for
Entry zone
$42.41 – $43.87
the fair-value band we waited for
Price at publication
$44.39
published May 25, 2026
Confidence
71%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Novo Nordisk offers steady exposure to healthcare because its diabetes and obesity treatments keep selling. The stock looks fairly valued and tends not to swing with the market, which makes gains likely to be modest. Recent competitive drug news and a weak earnings report mean the near-term outlook is cautious rather than fast growth.

Primary drivers

  • Strong ongoing demand for diabetes and obesity medicines
  • Reasonable valuation makes the stock a defensive option
  • Lower sensitivity to market swings reduces volatility in portfolios
  • Recent rival drug news limits near-term upside potential

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.